You have been chosen to receive this valuable information.
Introducing ambr® 15 Cell Culture Generation 2
Over the last 9 years, ambr® 15 has become the industry-standard microscale bioreactor system with more than 400 systems installed worldwide. Primarily used for clone selection and early fed-batch process development of CHO cell lines for mAb production, it has increasingly been adopted as an effective small-scale screening platform for many other applications and cell types including HEK293 for viral vector production, T-cell expansion, iPSCs, and other immune-derived cell lines.

ambr® 15 cell culture Generation 2 system has a new design which offers improved clone selection, media and feed optimization and early process development work both under fed-batch and perfusion mimic conditions. Cell and gene therapy applications are supported by the new design features and allow screening of more sensitive cell lines. In addition, the Generation 2 system includes a one year license of the new ambr® clone selection software application, powered by Umetrics.
Discover More
Suitable Applications
Offering a high level of flexibility and improved performance, the Generation 2 system is ideally suited for applications including:
Clone selection
Media and feed development
Early stage process optimization
Screening under perfusion mimic conditions
Development of advanced cell therapies
Learn More
System Features
ambr® 15 is the industry standard microbioreactor system implemented in laboratories worldwide. The Generation 2 system features:
New flexible deck layout
New expanded tip bin capacity
New liquid handler capability
New culture station design
New rapid vessel drain functionality
New clone selection software application
Download Brochure
Contact Us
 
About this Newsletter

Published by Sartorius AG
Otto-Brenner-Straße 20
37079 Goettingen, Germany
Phone +49.551.308-0
Fax +49.551.308-3289
news@sartorius.com

www.sartorius.com

If you do not wish to receive any more information from Sartorius, please click here.
 
Executive Board: Dr. Joachim Kreuzburg, René Fáber, Gerry Mackay, Rainer Lehmann
Chairman of the Supervisory Board:
Dr. Lothar Kappich

Local Court of Registration:
Amtsgericht Goettingen, HRB No. 1970
Vat No. DE 115 302 222

Registered Office:
Goettingen, Germany
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, a UBM publication. You are on the mailing list as %%emailaddress%%.